Skip to main content
OpenTrials

Clinical trial condition

CD33 Expressing Hematological Malignancies

Explore clinical trials studying CD33 Expressing Hematological Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

CD33 Expressing Hematological Malignancies trial results

Conditions
AML/MDS, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +33 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • TriStar Bone Marrow Transplant Nashville, Tennessee, United States